AVKARE Inc. recalls Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-
Recalled March 20, 2019 · FDA recall D-0990-2019 · AVKARE
Hazard
Failed Dissolution Specifications · FDA Class III
Units
a) 2947 and b) 3379
Sold at
Nationwide.
Description
Failed Dissolution Specifications
Product
Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478
Manufacturer(s)
AVKARE Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →